A new drug is making a splash in the herbal medicine world, and it is being heralded as a new way of treating the many chronic illnesses that afflict millions of Americans.
Key points:A new drug that is being hailed as an effective alternative for people suffering from chronic diseases has been hailed as a “miracle”The drug uses the body’s own natural defenses to combat cancerThe Drug Enforcement Agency has declared it safe for saleIt is also being hailed by some as a powerful alternative to pharmaceuticals, which are banned in most countries.
“I can’t even imagine the devastation it would have been like to live through if someone had died from the same disease that I have,” said Nancy Burd, a 62-year-old cancer survivor who has been treated for a variety of diseases by herbal medicines.
“This medicine is a miracle, I can’t believe this is actually being used in the U.S.,” she said.
The drug, called Nexium (sold under the brand name Nexiumx), uses the bodies own natural defense to combat some types of cancer.
Burd, who has experienced cancer and chronic fatigue syndrome, is hopeful that Nexium could help others.
“The Nexium family is just such a great family.
They are very supportive of the Nexium drug,” she said, adding that her family has helped many people with cancer and other diseases through the process of the drug’s development.
Nexiumx, which is a synthetic version of the cancer-fighting gene CRISPR, has been tested in mice and monkeys.
It was first approved by the FDA in the United States last summer, but only received the green light to begin commercial sales in the fall.
The agency has since declared it a safe and effective alternative, saying Nexium is a safe, effective, and cost-effective alternative to traditional cancer treatment.
It is unclear how many people have already taken Nexium.
The agency did not provide a breakdown of Nexium sales, but some experts estimate the drug is on the rise.
“It is certainly a very important development,” said Robert R. Smith, a professor at the University of California, Los Angeles School of Medicine, who was not involved in the study.
“There is no reason why it should not be available to all patients, including those with chronic diseases,” he said.
A number of major drug companies have already jumped on the Nexia hype, including Pfizer, Bristol-Myers Squibb, and Novartis.
The pharmaceutical industry has made some modest steps toward selling NexiumX, with the FDA recently issuing a preliminary approval for the drug.
The FDA’s preliminary approval also allows Pfizer and Novosciences to begin manufacturing Nexium, which means that Pfizer is expected to have about 200,000 units of NexiaX manufactured by the end of 2020.
However, there are also concerns about the efficacy of Nexii.
“These preliminary data suggest that Nexii is unlikely to offer the same robust benefit that Nexia does, and should be used only in rare cases of acute, life-threatening conditions,” said the agency.
The approval of Nexius, which has a longer list of conditions that it can treat, does not address the safety concerns, as the agency is reviewing the data before deciding whether to extend its approval.
However the new approval will not end Nexii’s fight against cancer.
The drug is being used as an adjuvant to traditional chemotherapy.
The National Cancer Institute has also issued a warning against NexiiX, noting that the drug can cause severe liver damage and other side effects, and that the drugs side effects may include nausea, vomiting, dizziness, headaches, muscle weakness, memory loss and other complications.
The NCCI is encouraging patients to wait until Nexiix has been cleared for use before using Nexii, but it has also urged those who have received Nexium to see their doctor before using it.
“As you become accustomed to the drug and begin to see the effects, you should continue to monitor your liver function to be aware of any side effects that might arise,” the agency said.
“If you or anyone in your family has any health conditions that could increase your risk for serious adverse reactions, you may want to talk to your doctor before beginning treatment.”
Read more about: